rustrated by White House efforts to tackle rising drug prices, a pair of U.S. lawmakers is urging the Trump administration to more squarely focus on drug makers — by backing legislation requiring them to justify their pricing and provide a breakdown of expenses before raising prices on some medicines.

In a letter to be sent on Monday to President Trump, Sens. Tammy Baldwin (D-Wis.) and John McCain (R-Ariz.) urge him to “make good on your promise” to fix a problem that is vexing an increasing number of Americans by backing the Fair Accountability and Innovative Research Drug Pricing Act, which they introduced last May. An identical bill was also introduced in the House, but both have languished.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Senators can scream and holler as much as they can about high drug prices. Irony is they are in Pharma pockets. Peggy Noonan in WSJ column [https://www.wsj.com/articles/i-love-a-parade-but-not-this-one-1518135401] very rightly says “Both parties are corrupt and look out only for themselves…” have no interest when they take funds to preserve their jobs. There is a saying “do not cut the hand that feeds you”.
    So legislators can hoot and holler but nothing will happen. People eventually will die whether they can afford drugs or not. It is just a question of time.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.